Anti-tumor immune responses of NDV-MIP3(a recombinant oncolytic Newcastle virus expressing MIP-3α) were partly reliant on CD8+ T cells and partially dependent on CD4+ T cells [120]. The gene discussed is CD8A; the disease is neoplasm.